Zepp Health Q2 Adj EPS $(0.13) Up From $(0.26) YoY, Sales $89.40M Down From $165.46M YoY
Portfolio Pulse from Benzinga Newsdesk
Zepp Health reported Q2 adjusted losses of $(0.13) per share, a 50% improvement from $(0.26) per share YoY. However, sales decreased by 45.97% to $89.40 million from $165.46 million YoY.
August 21, 2023 | 10:17 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Zepp Health's Q2 results show a significant improvement in losses but a substantial decrease in sales YoY.
While Zepp Health has managed to reduce its losses significantly, the substantial decrease in sales could be a concern for investors. The mixed results make the short-term impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100